Cite
APA Citation
Kato, K., Shah, M., Enzinger, P., Bennouna, J., Shen, L., Adenis, A., Sun, J., Cho, B., Ozguroglu, M., Kojima, T., Kostorov, V., Hierro, C., Zhu, Y., Shah, S., Bhagia, P., & Doi, T. (n.d.). p-052A phase 3 study of chemotherapy + pembrolizumab versus chemotherapy + placebo as first-line therapy for patients with advanced esophageal or esophagogastric junction (E/EGJ) cancer: KEYNOTE-590 - Trial in progress. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095520761.0x00002d